Related Experiment Video
Updated: Aug 7, 2026
10:45
Organotypic Collagen I Assay: A Malleable Platform to Assess Cell Behaviour in a 3-Dimensional Context
Published on: October 13, 2011
A possible role for enzymes in tumour-cell invasion
C H van Aswegen1, D J du Plessis
1Department of Urology, University of Pretoria, South Africa.
Medical Hypotheses
|May 1, 1997
Summary
This study summarizes molecular processes in cancer cell invasion and potential anti-invasion strategies. Understanding these factors is crucial for developing effective cancer therapies and improving patient prognosis.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Neoplastic cell invasion is a significant barrier in cancer treatment.
- Extracellular matrix degradation by enzymes facilitates cancer metastasis.
- Enzymes like matrix metalloproteinases play key roles in invasion.
Purpose of the Study:
- To summarize the molecular and cellular mechanisms of metastatic invasion.
- To explore the possibilities of inhibiting cancer cell invasion.
- To highlight the need for further research into invasion promoters and suppressors.
Main Methods:
- Literature review and synthesis of existing research on cancer invasion.
- Identification of key enzymes involved in extracellular matrix breakdown.
- Analysis of known invasion inhibitors and promoters.
Main Results:
- Several enzymes (e.g., hyaluronidase, urokinase-type plasminogen activator, matrix metalloproteinases) are central to extracellular matrix catabolism during invasion.
- Enzyme inhibitors can counteract the invasive process.
- Both invasion-promoting and invasion-suppressing factors are critical.
Conclusions:
- Further investigation into invasion factors is essential for understanding cancer aetiology.
- Identifying and targeting these factors may offer new therapeutic strategies for metastatic cancer.
- Understanding invasion mechanisms can improve cancer treatment and prognosis.
Related Concept Videos
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:35Cancer Cell Migration through Invadopodia
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...